Lundbeck

For more than 70 years, Lundbeck has been at the forefront of neuroscience research. We are committed to developing and providing innovative therapies that improve the quality of life for people affected by psychiatric and neurological disorders. When we assess a medical condition, we see the person behind the disease, and we have deep connections with the communities we serve. In the United States, our 900+ employees stand shoulder-to-shoulder with patients, families and caregivers impacted by brain disorders.

Lundbeck Bothell, WA, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Washington, DC, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck New York, NY, USA
Jun 18, 2020
The Market Access Regional Account Manager will maximize profitable access for Lundbeck’s U.S. portfolio of promoted products through development and maintenance of key relationships with leading targeted regional, local, and strategic healthcare payers. The position is responsible for implementing short and long-term business initiatives to ensure appropriate coverage and pull-through programs, in collaboration with internal stakeholders, as well as creating business cases to leverage contract terms within established corporate guidelines.   ESSENTIAL FUNCTIONS Engages in account portfolio planning using utilization data, and knowledge of therapeutic class management behavior by targeted plans, to determine prioritization of activities that will maximize returns for Lundbeck Creates business plans for targeted accounts that include clinical and economic elements to gain or improve product access  Demonstrates resourcefulness in penetrating multiple...
Lundbeck Manhattan, New York, NY, USA
Jun 18, 2020
The Market Access Regional Account Manager will maximize profitable access for Lundbeck’s U.S. portfolio of promoted products through development and maintenance of key relationships with leading targeted regional, local, and strategic healthcare payers. The position is responsible for implementing short and long-term business initiatives to ensure appropriate coverage and pull-through programs, in collaboration with internal stakeholders, as well as creating business cases to leverage contract terms within established corporate guidelines.   ESSENTIAL FUNCTIONS Engages in account portfolio planning using utilization data, and knowledge of therapeutic class management behavior by targeted plans, to determine prioritization of activities that will maximize returns for Lundbeck Creates business plans for targeted accounts that include clinical and economic elements to gain or improve product access  Demonstrates resourcefulness in penetrating multiple...
Lundbeck Bothell, WA, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Boston, MA, USA
Jun 18, 2020
The Market Access Regional Account Manager will maximize profitable access for Lundbeck’s U.S. portfolio of promoted products through development and maintenance of key relationships with leading targeted regional, local, and strategic healthcare payers. The position is responsible for implementing short and long-term business initiatives to ensure appropriate coverage and pull-through programs, in collaboration with internal stakeholders, as well as creating business cases to leverage contract terms within established corporate guidelines.   ESSENTIAL FUNCTIONS Engages in account portfolio planning using utilization data, and knowledge of therapeutic class management behavior by targeted plans, to determine prioritization of activities that will maximize returns for Lundbeck Creates business plans for targeted accounts that include clinical and economic elements to gain or improve product access  Demonstrates resourcefulness in penetrating multiple...
Lundbeck Portland, OR, USA
Jun 18, 2020
The Market Access Regional Account Manager will maximize profitable access for Lundbeck’s U.S. portfolio of promoted products through development and maintenance of key relationships with leading targeted regional, local, and strategic healthcare payers. The position is responsible for implementing short and long-term business initiatives to ensure appropriate coverage and pull-through programs, in collaboration with internal stakeholders, as well as creating business cases to leverage contract terms within established corporate guidelines.   ESSENTIAL FUNCTIONS Engages in account portfolio planning using utilization data, and knowledge of therapeutic class management behavior by targeted plans, to determine prioritization of activities that will maximize returns for Lundbeck Creates business plans for targeted accounts that include clinical and economic elements to gain or improve product access  Demonstrates resourcefulness in penetrating multiple...
Lundbeck Dallas, TX, USA
Jun 18, 2020
The Market Access Regional Account Manager will maximize profitable access for Lundbeck’s U.S. portfolio of promoted products through development and maintenance of key relationships with leading targeted regional, local, and strategic healthcare payers. The position is responsible for implementing short and long-term business initiatives to ensure appropriate coverage and pull-through programs, in collaboration with internal stakeholders, as well as creating business cases to leverage contract terms within established corporate guidelines.   ESSENTIAL FUNCTIONS Engages in account portfolio planning using utilization data, and knowledge of therapeutic class management behavior by targeted plans, to determine prioritization of activities that will maximize returns for Lundbeck Creates business plans for targeted accounts that include clinical and economic elements to gain or improve product access  Demonstrates resourcefulness in penetrating multiple...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Boston, MA, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...
Lundbeck Deerfield, IL, USA
Jun 18, 2020
At Lundbeck, we are tirelessly dedicated to restoring brain health so every person can be their best. Headquartered in Copenhagen with sites worldwide including in Bothell, Washington, Lundbeck is the only global biopharmaceutical company focused solely on brain diseases. Our legacy in neuroscience goes back seven decades and we have a long heritage of innovation. Lundbeck has developed and commercialized some of the world’s most widely prescribed therapies for psychiatric and neurological disorders. Today, we remain uncompromisingly committed to improving the quality of life for people impacted by brain disorders. Lundbeck is unique from other biopharmaceutical companies in that we are 70 percent owned by a research-focused foundation. We have a deep and productive pipeline, and we continue to bring forward symptomatic therapies to help people live better lives, while simultaneously pursuing disease-modifying treatments. In October 2019, Lundbeck acquired Alder...